相关实验视频

Updated: Mar 17, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

什科宁:解开它的多机制抗癌和抗炎机制

Hui Tan^1,2, Jielong Li^1,3, Jie Li^1,3

¹Department of Cardiothoracic Surgery, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng, 224000, People's Republic of China.

Current medicinal chemistry

|March 15, 2026

概括

石康宁是一种天然化合物,通过抑制关键通路,有效调节炎症和免疫力. 它还通过诱导亡和抑制瘤生长来显示出作为抗癌剂的希望,尽管毒性需要进一步研究.

科学领域:

自然产品化学自然产品化学
药理学药理学是指药理学的学科.
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

石素,一种来自Lithospermum erythrorhizon的纳夫托基,表现出抗炎,免疫调节和抗瘤的特性.
它的机制包括抑制NF-κB和MAPK信号通路,调节Th17/Treg平衡,影响瘤细胞亡,增殖和新陈代谢.

研究的目的:

阐明shikonin在调节炎症免疫网络中的多目标机制.
探索shikonin作为一种低毒性纳夫托基基抗癌剂的潜力.

主要方法:

审查现有的关于shikonin的药理活动和作用机制的文献.
对什科宁对炎症信号通路和免疫细胞平衡的影响的分析.
评估shikonin的抗癌作用,包括诱导细胞灭绝,抑制增殖和代谢干扰.

主要成果:

石康宁抑制促炎性细胞因子 (TNF-α,IL-8) 并调节Th17/Treg平衡,改善自身免疫性疾病.
它诱导瘤细胞亡,抑制扩散和转移,并干扰癌细胞代谢.
石康宁在体外表现出广泛的抗癌活性,但临床应用因毒性而受到限制.

结论:

石康宁具有"一种药物,多种效应"的特征,影响着炎症免疫反应和癌症.
需要进行结构修改,以提高shikonin的选择性和临床使用的安全性.
石康宁具有作为一种新型免疫调节剂和更安全的抗癌剂的潜力.

关键词:

在西康尼尼 (Shikonin) 书房里.灭症 (apoptosis) 是一种死亡的过程.中国草药医学的中国草药.免疫细胞.免疫细胞.免疫疾病是一种免疫疾病.分子机制的分子机制.自然产品是自然产品的产品.瘤是一个瘤.

相关概念视频

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...